Prescription and dosing of urate-lowering therapy ... - Semantic Scholar
Recommend Documents
Sep 16, 2012 - (n = 181), allopurinol dose, patient confidence to keep SU under control, female sex, and ethnicity were independently associated with SU ...
Repeat dosing of rocuronium-sugammadex: unpredictable. Yoon-Hee Kim. Department of Anesthesiology and Pain Medicine, Chungnam National University ...
Jul 2, 2018 - Erwin, J.O.; Britten, N.; Jones, R. Pharmacists and deregulation: The case of ... Eickhoff, C.; Hämmerlein, A.; Griese, N.; Schulz, M. Nature and ...
'Absolute indefinite future [SF]: ''That will be, since God said so.'' Absolute definite remote .... morphosyntax across the lifespan (Bailey 2002, Bailey et al. 1991 ...
Mar 25, 2013 - primary care trimethoprim prescribing and Escherichia coli (E. coli) trimethoprim resistance in all urinary isolates in children resident in a ...
and abused: Adderall®, Adderall XR®, Ativan®, Concerta®,. Duragesic®, Fentora®, OxyContin®, Percocet®, Ritalin®,. Valium®, Vicodin®, and Xanax®. Hence ...
May 15, 2015 - negative partial correlation with the daily costs of total, internal, and injection medicines as well as medical devices. Moreover, the rate of ...
May 13, 2008 - behavior; pharmaceutical marketing; patient-level data. J Gen Intern Med .... studies have shown that âdirect mail to physicians is very inefficient ... government legislation, is not in anyone's best interest. Without PDRP ...
Dec 6, 2011 - pharmacovigilance databases: the example of sertindole. Pharmacoepidemiol. Drug Saf 12: 271â281. Dear Doctor Letter for Oseltamivir Safety ...
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology ... Published Online February 2014 (http://www.scirp.org/journal/ijmpcero).
aminoglycosides in hemodialysis patients is limited by ototoxicity and vestibular toxicity, which could be as high as 30% (1). Ami- noglycoside efficacy is related ...
cephalosporins, vancomycin and ciprofloxacin dosing in critically ill patients. ... renal function, a more frequent administration than single daily dosing may be ...
Correspondence: Marwan sheikh-Taha. Department of Pharmacy Practice, lebanese American University,. PO Box 36, Byblos, lebanon. Fax +1 801 761 2883.
Feb 5, 2016 - Midlands, United Kingdom, 3 School of Sport, Ulster University, Shore Road, ... 4 [email protected] ...... Hall EE, Ekkekakis P, Petruzzello SJ.
Hypertension, Department of Medicine, Oregon Health & Science University, Portland, Oregon; â¡Division of Hospital .... (PVAMC) institutional review board.
Jennifer R Shiu and Mary H H Ensom. ABSTRACT. Background: ...... Jansson LM, DiPietro JA, Velez M, Elko A, Knauer H, Kivlighan KT. Maternal methadone ...
require dose-response and potency data to facilitate risk assess- ment ...... EPA-. HQ-ORD-2006-0500] Available at: http://www.regulations.gov/search/Regs/.
Apr 8, 2014 - Medicine on Its Cost in Japanese Prefectures. Masayuki Yokoi1 .... Japan has a universal national health insurance system. Consequently, all ...
Another large ECT machine manufacturer, MECTA Corpora- tion, recommends this method of stimulus selection with the use of their machines.16 This method is ...
Studies assessing Chinese herbal medicine, Ayurvedia,. Kampo, Siddha, Unani, homoeopathic remedies, non- herbal dietary supplements and vitamins will be ...
Herescon GmbH, which received payment from AbbVie to assist with the research. ... stock in AbbVie, Inc. The authors and AbbVie scientists designed the study,.
the Department of Medicine, University of California, San Francisco, CA, USA; Garfein is with the. Department of ..... as police calls and arrests could further elucidate these issues. As part of .... sales to injection drug users in Denver, Colorado
Liu et al. BMC Complementary and Alternative Medicine (2016) 16:397 ... a negative response [10]. To provide ... fined as patients with HC (ICD-9-CM codes 07054,. 0707 ..... Certain conditions originating in the perinatal period (760â779). 13. 0.45
Prescription and dosing of urate-lowering therapy ... - Semantic Scholar
Sep 16, 2012 - ... Horne1, Keith J Petrie2, Fiona M McQueen3 and William J Taylor4 ..... Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF: ...
Dalbeth et al. BMC Musculoskeletal Disorders 2012, 13:174 http://www.biomedcentral.com/1471-2474/13/174
RESEARCH ARTICLE
Open Access
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout Nicola Dalbeth1*, Meaghan E House1, Anne Horne1, Keith J Petrie2, Fiona M McQueen3 and William J Taylor4
Abstract Background: Long term serum urate (SU) lowering to a target of
